Literature DB >> 25931020

De novo SHANK3 mutation causes Rett syndrome-like phenotype in a female patient.

Munetsugu Hara1, Chihiro Ohba2, Yushiro Yamashita3, Hirotomo Saitsu2, Naomichi Matsumoto2, Toyojiro Matsuishi3.   

Abstract

Rett syndrome (RTT) is a neurodevelopmental disorder predominantly affecting females. Females with the MECP2 mutations exhibit a broad spectrum of clinical manifestations ranging from classical Rett syndrome to asymptomatic carriers. Mutations of genes encoding cyclin-dependent kinase-like 5 (CDKL5) and forkhead box G1 (FOXG1) are also found in early onset RTT variants. Here, we present the first report of a female patient with RTT-like phenotype caused by SHANK3 (SH3 and multiple ankylin repeat domain 3) mutation, indicating that the clinical spectrum of SHANK3 mutations may extend to RTT-like phenotype in addition to (severe) developmental delay, absence of expressive speech, autistic behaviors and intellectual disability.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Rett syndrome; SHANK3; de novo; deletion; frameshift; whole-exome sequencing

Mesh:

Substances:

Year:  2015        PMID: 25931020     DOI: 10.1002/ajmg.a.36775

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  10 in total

Review 1.  Genetic Findings as the Potential Basis of Personalized Pharmacotherapy in Phelan-McDermid Syndrome.

Authors:  Brianna Dyar; Erika Meaddough; Sara M Sarasua; Curtis Rogers; Katy Phelan; Luigi Boccuto
Journal:  Genes (Basel)       Date:  2021-07-30       Impact factor: 4.096

Review 2.  Rett Syndrome Spectrum in Monogenic Developmental-Epileptic Encephalopathies and Epilepsies: A Review.

Authors:  Carlotta Spagnoli; Carlo Fusco; Francesco Pisani
Journal:  Genes (Basel)       Date:  2021-07-28       Impact factor: 4.096

3.  Clinical presentation of Rett syndrome in relation to quality of life and family functioning.

Authors:  Anna Rozensztrauch; Agnieszka Sebzda; Robert Śmigiel
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

4.  Case report: an unexpected link between partial deletion of the SHANK3 gene and Heller's dementia infantilis, a rare subtype of autism spectrum disorder.

Authors:  Anne Philippe; Yann Craus; Marlène Rio; Nadia Bahi-Buisson; Nathalie Boddaert; Valérie Malan; Jean-Paul Bonnefont; Laurence Robel
Journal:  BMC Psychiatry       Date:  2015-10-21       Impact factor: 3.630

5.  The Quality of Life in Girls with Rett Syndrome.

Authors:  Lucia Parisi; Teresa Di Filippo; Michele Roccella
Journal:  Ment Illn       Date:  2016-05-18

6.  Transcriptome analysis of microglia in a mouse model of Rett syndrome: differential expression of genes associated with microglia/macrophage activation and cellular stress.

Authors:  Dejian Zhao; Ryan Mokhtari; Erika Pedrosa; Rayna Birnbaum; Deyou Zheng; Herbert M Lachman
Journal:  Mol Autism       Date:  2017-03-29       Impact factor: 7.509

7.  Epilepsy and genetic in Rett syndrome: A review.

Authors:  Francesca Felicia Operto; Roberta Mazza; Grazia Maria Giovanna Pastorino; Alberto Verrotti; Giangennaro Coppola
Journal:  Brain Behav       Date:  2019-03-30       Impact factor: 2.708

Review 8.  Genetic Landscape of Rett Syndrome Spectrum: Improvements and Challenges.

Authors:  Silvia Vidal; Clara Xiol; Ainhoa Pascual-Alonso; M O'Callaghan; Mercè Pineda; Judith Armstrong
Journal:  Int J Mol Sci       Date:  2019-08-12       Impact factor: 5.923

9.  Neuromotor Development in the Shank3 Mouse Model of Autism Spectrum Disorder.

Authors:  Miriam Pillerová; Diana Drobná; Jakub Szabó; Emese Renczés; Veronika Borbélyová; Daniela Ostatníková; Peter Celec; Ľubomíra Tóthová
Journal:  Brain Sci       Date:  2022-06-30

10.  Whole exome sequencing of Rett syndrome-like patients reveals the mutational diversity of the clinical phenotype.

Authors:  Mario Lucariello; Enrique Vidal; Silvia Vidal; Mauricio Saez; Laura Roa; Dori Huertas; Mercè Pineda; Esther Dalfó; Joaquin Dopazo; Paola Jurado; Judith Armstrong; Manel Esteller
Journal:  Hum Genet       Date:  2016-08-19       Impact factor: 4.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.